The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...

The global clinical trials market was valued at USD 60.56 billion in 2024 and is predicted to surge USD 92.12 billion by 2033 with a registered CAGR of 4.84% during the forecast period 2024 to 2033.

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial success.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

An official who oversees a team at the Food and Drug Administration that reviews Neuralink Corp. devices was fired, according to an email the agency sent to staff Tuesday morning viewed by Bloomberg.

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or dead tissue from chronic wounds in multiple Phase II trials.

Sedana Medical AB (publ) announces that its second pivotal US trial INSPiRE-ICU 2 has met its primary endpoint, and hence established non-inferiority of inhaled sedation with isoflurane compared with ...

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.11 million, is ...

The company anticipates finishing these trials between late 2025 and early ... and potential classification as a Class III medical device. Despite challenging market conditions, the company ...